The effects of exposure to environmental chemicals on child development by Berghuis, Sietske Anette
  
 University of Groningen
The effects of exposure to environmental chemicals on child development
Berghuis, Sietske Anette
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2018
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Berghuis, S. A. (2018). The effects of exposure to environmental chemicals on child development.
[Groningen]: University of Groningen.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
PART 3
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Polychlorinated biphenyl exposure and 
deiodinase activity in young infants 
Shalini D. Soechitram, Sietske A. Berghuis, Theo J. Visser, Pieter J.J. Sauer





Background: Several studies have shown effects of polychlorinated biphenyls (PCBs) on 
serum thyroid hormone levels in pregnant woman and their infants, while other studies 
did not find such effects. How PCBs might affect thyroid hormone metabolism, is still 
unclear. Potential mechanisms are direct influence on the thyroid gland, binding to thyroid-
binding proteins, increased excretion or metabolism of thyroid hormones by deiodinases or 
sulfatases. It is also not well known whether the effect on thyroid hormone levels is caused 
by PCBs themselves, or by their hydroxylated metabolites (OH-PCBs). 
Objective: To determine the effects of perinatal exposure to PCBs and OH-PCBs on thyroid 
hormone levels in cord blood and in serum of newborn infants.
Methods: In a Dutch cohort of 100 mother-infant pairs, exposed to background PCB levels, 
correlations were assessed between 10 PCBs and 6 OH-PCBs in maternal blood during 
pregnancy and serum thyroxine (T4), T4 sulfate (T4S), triiodothyronine (T3), reverse T3 
(rT3), thyroid-stimulating hormone (TSH) and thyroid-binding globulin (TBG) levels in cord 
blood and in serum of three- and 18-month-old infants.
Results: Prenatal levels of six of 10 measured PCBs showed a positive correlation with cord 
serum T3, and 4 PCBs showed a negative correlation with cord serum rT3. Five of these PCBs 
were positively correlated with the cord serum T3/rT3 ratio, an indicator of deiodinase 
3 activity. No correlations were found between PCBs and T4, TSH and TBG in cord blood. 
4-OH-PCB-107 was correlated with T4 at 3 months and T4, T4S and T3 at 18 months.
Conclusion: Our results suggest that PCBs have a negative effect on deiodinase type 
3 activity, as reflected by a positive correlation with the T3/rT3 ratio. We identified a 
potential mechanism by which PCBs may affect thyroid hormone metabolism during human 
development. 
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INTRODUCTION
Despite the ban on their production decades ago, polychlorinated biphenyls (PCBs) are 
still present in the environment and in human tissues.1, 2 Levels of PCBs are higher in more 
densely populated countries such as the Netherlands and Belgium compared to countries 
such as the USA and Canada.2-5 Levels in the Netherlands seem to decrease, when comparing 
cohorts from 1990-1992 and 2011-2013 with mean levels of PCB 153 of 91 ng/L and 35 
ng/L, respectively, in the first and second period.6, 7 A study from Belgium from 2007 
showed a PCB-153 level in cord blood of 70 ng/L.8 Levels are decreasing due to the ban on 
the production of these compounds. Different studies found negative effects of prenatal 
exposure to these compounds on thyroid hormone levels (THs), and on neurodevelopment of 
infants. In a cohort in The Netherlands in the early nineties, negative effects of PCBs on THs 
were found.6 In contrast, a later study in Germany did not show an effect of background PCB 
levels on TH status.9 Studies have shown lower levels of thyroxine (T4) and tri-iodothyronine 
(T3) in pregnant women in relation to PCB exposure.6, 10, 11 Maternal T4 is an important 
source of TH for the fetus. Decreased maternal levels of T4 can have negative effects 
on the fetal neurodevelopment. The development of the central nervous system depends 
on the concentration of THs, and therefore may be at risk for PCB-induced alterations 
in brain TH concentrations.12 In a Dutch cohort in the early nineties, negative effects of 
exposure to PCBs on neurodevelopment were found.4, 13 Also in the cohort of the current 
study, associations were found between prenatal exposure to PCBs and neurodevelopment 
at the age of three months.14, 15
Studies in humans mainly investigated the effect of PCBs themselves on human 
development. PCBs are metabolized by hydroxylation to OH-PCBs, which are more water-
soluble and therefore more rapidly excreted from the body.2 Some OH-PCBs have a higher 
affinity for transthyretin (TTR) than T4 itself.16 Animal studies showed that OH-PCBs can 
accumulate in the brain of the fetal rat, thereby reducing fetal brain T4 levels. This 
reduction in brain T4 levels is partially compensated by increased type 2 deiodinase (D2) 
activity, a well-known response of the rat brain to maintain brain T3 levels when circulating 
T4 concentrations are decreased.12, 17, 18
A study showed a negative correlation between cord blood levels of 4-OH-PCB-107 and 
mental and psychomotor development in children at 16 months of age.10 In the cohort of 
the current study, prenatal exposure to 4-OH-PCB-107 was found to be negatively associated 
with neurodevelopment at three months.14, 15
Not much is known on how PCBs might affect thyroid function in the human fetus and 
newborn infant. In animals the most likely mechanism is binding of PCBs to transthyretin 
(TTR). In humans, thyroid-binding globulin (TBG) is the most prominent TH-binding 
protein.17 TTR plays a role in mediating the delivery of T4 across the blood-brain barrier 
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and transferring T4 from the mother to the fetus. Thus, it may still be possible that binding 
of PCBs to TTR may play an important role on thyroid function in the human fetus. Other 
potential mechanisms influencing TH levels in humans are changes in the activities of TH 
metabolizing enzymes as deiodinases and sulfotransferases. Schuur et al. studied different 
iodothyronine sulfotransferases catalyzing the sulfation of THs in humans and in rats.19 They 
found that TH sulfation is potently inhibited by hydroxylated metabolites of various PCBs. 
Whether PCBs have effects on the TH deiodinase or sulfatase activity in newborn infants is 
still not clear.
The aim of this study was to measure the thyroid hormone status of newborn infants 
in cord blood and at 3 and 18 months and to evaluate the effect of PCBs and OH-PCBs on 




This study is part of a prospective study on the exposure to PCBs and OH-PCBs and their 
potential effect on the development of the newborn infant.2 From September 1998 to 
December 2000, pregnant women from the Northern part of The Netherlands were invited by 
their midwife or obstetrician to participate in a study on the exposure to PCBs and OH-PCBs 
and their potential effect on the development of the newborn infant. Mothers had to be of 
Western European origin, and Dutch had to be their native language. Pregnancy and delivery 
had to be without complications. Only infants born at term (37-42 weeks of gestation) with 
a birth weight above -2SD and without congenital abnormalities were included Admission 
of an infant to the hospital for more than one day after birth was an exclusion criterion. In 
total, 104 mother-infant pairs were included in the cohort. The Medical Ethical Committee 
of the University Medical Centre Groningen approved the study.
Measurements of PCBs and OH-PCBs
Results of the measurements of the prenatal levels of PCBs and OH-PCBs in a part of the 
cohort have been published previously.2 In short, blood samples were taken from the 
pregnant women in the third trimester of pregnancy for measurement of the levels of 10 
PCB congeners and 6 OH-PCBs, as shown in Table 2. PCBs and OH-PCBs were measured using 
a gas chromatograph (Varian 3400 GC) equipped with an electron capture detector, a Varian 
822\00 autosampler and a split/splitless injector operated in a splitless mode. The fused 
silica-capillary column used was a non-polar column, CP-SIL 8CB (25 m x 0.15 mm x 0.12 
μm) from Chrompack (Middelburg, The Netherlands). The chemical activated luciferase 
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gene expression (Calux) essay was used for measuring total Toxic Equivalent Quotient (TEQ) 
levels in maternal serum. Calux can be used to detect certain planar halogenated aromatic 
hydrocarbons (PHAH), including PCBs. The binding of the compounds to the aryl hydrocarbon 
receptor (AhR) is followed by transportation of the PHAH-AhR complex into the nucleus of 
the cell, and subsequent binding to specific sequences in the DNA (BioDetection Systems).
Thyroid hormone parameters at three and 18 months of age
Cord blood, as well as blood taken from the infants by vena puncture at the age of 3 and 
18 months, was collected for the determination of T4, T4 sulfate (T4S), thyroid stimulating 
hormone (TSH), T3, reverse T3 (rT3) and TBG. All blood samples were analyzed within one year 
after collection. Serum T4, T3 and rT3 were measured by in-house radioimmunoassay; TSH 
by Dynotest IRMA; and TBG by Dynotest RIA (Brahms, Berlin, Germany). The measurements 
of serum T4S were performed by radioimmunoassay (Murphy et al., 2004). Within-assay 
coefficients of variation were calculated as 2-8% for T4, 2-6% for T3, 3-4% for rT3, 6-17% 
for T4S, 2-5% for TSH and 2-4% for TBG. Between-assay coefficients of variation were 5-10% 
for T4, 8% for T3, 9-16% for rT3, 4-19% for T4S, 2-14% for TSH, and 2-3% for TBG. Thyroid 
hormones were normally distributed.
Statistic analyses
Results are presented as mean and standard deviation where appropriate. PCB levels are 
expressed on lipid weight basis (ng/g lipid) and OH-PCB levels on fresh weight basis (ng/g 
serum). The PCB and OH-PCB levels are presented as median and range. Bivariate non-
parametric correlations were calculated using Spearman rank correlation test. To determine 
whether the association between PCBs and OH-PCBs and the TH parameters was confounded 
by other characteristics (age of the mother, gender, gestational age, type of feeding), we 
performed univariate logistic regression analyses. These characteristics were considered as 
possible confounders if they had a P-value of less than .20 in the univariate analysis model. 
We performed multivariate logistic regression analyses (method: enter) to assess whether 
these confounders had influenced our results. Differences were considered statistically 
significant at P<0.05 level. All statistical analyses were performed using Statistical Package 
for the Social Sciences (SPSS), version 22.
RESULTS
Study group
Of the 104 mother-infant pairs initially included in the cohort, PCB or OH-PCB and thyroid 
hormone metabolism parameters were measured in 100 mother-infant pairs. Clinical details 
of the study group are presented in Table 1. 
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Table 1. Characteristics of the study group (N=100 mother-infant pairs)
Characteristic Value
Gender, boy/girl 53/47
Gestational age (weeks) 40 (37-42)
Birth weight (grams) 3629 ± 499
Type of feeding, breast/formula 71/29
Maternal age (years) 32 ± 4
Maternal smoking [yes/no] 23/77
Data are given as frequencies (n/n), median (min-max), or mean ±SD
Levels of PCBs, OH-PCBs and thyroid hormone parameters
Levels of both dioxin-like and non-dioxin-like PCBs and OH-PCBs and Calux measured in 
maternal serum during the third trimester of pregnancy are shown in Table 2. PCB-153 was 
the most prevalent congener, followed by PCB-138. The median sum of 10 PCBs (ng/g lipid 
weight) was 293.4 with IQR 216.5-390.4. For six OH-PCBs, the median sum was 19.55 ng/g 
(fresh weight) with IQR 14.43-59.53 ng/g. Calux results were positively correlated with the 
individual dioxin-like PCBs and the sum of the measured dioxin-like PCBs (Supplementary 
Table 1). Serum TH levels are shown in Table 3. All values of T4, T3 and TSH were within the 
normal range for our laboratory. Normal values for T4S, rT3 and TBG are not available for 
newborns in our laboratory.
Table 2. PCB- and OH-PCB-levels in maternal serum during pregnancy
Compound Median (IQR) n
PCB-105 4.2 (2.1-11.1) 100
PCB-118 21.0 (14.7-33.3) 100
PCB-138 68.4 (48.0-85.8) 100
PCB-146 8.1 (4.7-13.0) 100
PCB-153 90.5 (63.5-121.1) 100
PCB-156 11.1 (7.7-14.1) 98
PCB-170 19.0 (13.3-25.0) 98
PCB-180 44.7 (31.4-58.1) 98
PCB-183 8.2 (5.6-10.4) 100
PCB-187 12.0 (8.7-17.1) 100
Sum PCBsa 293.4 (216.5-390.4) 98
Sum dl-PCBsb 38.7 (24.6-60.7) 98
Sum non-dl-PCBsc 252.7 (180.3-334.3) 98
4-OH-PCB-107 0.065 (0.041-0.101) 97
3’-OH-PCB-138 0.045 (0.031-0.065) 97
4-OH-PCB-146 0.070 (0.052-0.101) 97
3-OH-PCB-153 0.037 (0.024-0.054) 97
4’-OH-PCB-172 0.016 (0.010-0.022) 77
4-OH-PCB-187 0.136 (0.105-0.175) 97
Sum OH-PCBsd 0.386 (0.281-0.531) 97
Calux 19.55 (14.43-59.53) 98
PCBs in ng/g lipid weight; OH–PCBs in ng/g fresh weight; Calux levels in pg TEQ/g lipid; a sum of all 10 
PCBs; b sum of dioxin-like PCBs (105; 118; 156); csum of non-dioxin-like PCBs (138; 146; 153; 170; 180; 
183; 187); d sum of all measured 6 OH-PCBs.
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Table 3. Plasma thyroid hormone parameter levels in cord and serum of infants at 3 and 18 months 
of age
Thyroid hormone parameter Umbilical cord Serum 3 months Serum 18 months
Mean±SD n  Mean±SD n  Mean±SD n
T4 (nmol/L) 126.3±26.7 87  132.2±21.7 90  114.9± 18.1 85  
T4S (pmol/L) 485.0±177.1 86  50.3±20.3 88   21.7±12.6 83  
TSH (mU/L) 13,9±8.19  86  3.32±1.52 90   3.25±1.39 84  
T3 (nmol/L) 0.71±0.24  85  2.78±0.38 89   2.42±0.32 84  
rT3 (nmol/L) 3.7±1.22 85   0.56±0.14 87    0.32±0.06 84    
TBG (mg/L) 30.3±6.10 86   30.0±6.16 90    25.7±4.31 84    
T4-TBG ratio 4.20±0.54 86   4.50±1.02 90    4.52±0.57 84    
T3-rT3 ratio 0.22±0.14 85  5.25±1.54 87  7.73±1.66 84
T4:thyroxine; T4S:T4 sulfate; TSH:thyroid stimulating hormone; T3:tri-iodothyronine; rT3:reverse T3; 
TBG:thyroid-binding globulin
Correlations between PCBs, OH-PCBs and thyroid hormone parameters
A significant positive correlation was found between PCB 118, 146, 153, 138, 187, 183, as 
well as the sum of PCB levels (sum of 10 PCBs measured, see Table 2) with cord serum T3 
levels. A significant negative correlation was found between 4 of these 6 PCBs and the sum 
of all measured PCBs with cord serum rT3 (Table 4a). Exposure to PCBs 118, 146, 153, 138 
and 187 showed a positive correlation with the T3/rT3 ratio (all p < 0.01). The sum of both 
the dioxin-like as well as the non-dioxin-like PCBs showed a significant correlation with the 
T3/rT3 ratio. No correlation between any of the PCBs or OH-PCBs and cord T4, TSH, T4S 
or TBG was found. Also no correlation was found between the Calux results and any of the 
cord TH levels. 
At three months, 4-OH-PCB-107 and 4-OH-PCB-187 showed a positive correlation with 
T4. The results of the Calux showed a positive correlation with T4S and rT3 (Table 4b). At 
18 months, 4-OH-PCB-107 showed a positive correlation with T4S, T4 and T3. The sum of 
OH-PCBs also showed a positive correlation with T4S and T3 (Table 4c).
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Table 4a. Spearman’s rho correlations between prenatal PCB and OH-PCB levels and T3, rT3 in cord 
blood
Compound T3 (nmol/L) rT3 (nmol/L) Ratio T3-rT3
Rho P-value Rho  P-value Rho P-value
PCB-118 0.279 0.010** -0.237 0.029* 0.307 0.004**
PCB-138 0.259 0.017* -0.235 0.030* 0.301 0.005**
PCB-146 0.343 0.001** -0.271 0.012* 0.356 0.001**
PCB-153 0.263 0.015* -0.210 0.054 0.284 0.008**
PCB-183 0.224 0.040* -0.037 0.734 0.156 0.153
PCB-187 0.320 0.003** -0.223 0.040* 0.321 0.003**
Sum PCBsa 0.279 0.011* -0.224 0.042* 0.300 0.006**
Sum dl-PCBsb 0.253 0.021* -0.215 0.051 0.270 0.014*
Sum non-dl-PCBsc 0.274 0.012* -0.217 0.049* 0.297 0.006**
Calux -0.075 0.502 0.053 0.633 -0.100 0.367
a sum of all 10 measured PCBs; bsum of dioxin-like PCBs (105; 118; 156); sum of non-dioxin-like PCBs 
(138; 146; 153; 170; 180; 183; 187); T3:tri-iodothyronine; rT3:reverse T3;*P<0.05;**P< 0.01
Correction for confounders
We investigated whether factors might have confounded our findings by determining the 
odds ratios (ORs) for their effect on TH parameters. Univariate logistic regression analyses 
in cord blood revealed that higher age of the mother (OR=1.127; P=0.037) and female 
gender (OR=2.745; P=0.024) were associated with higher T3 (above the 50th percentile), and 
higher gestational age (OR=1.980; P=0.005) was associated with higher T3/rT3 ratio. Table 
5 shows univariate logistic regression analyses, and multivariate logistic regression analyses 
to correct for confounders.
Univariate logistic regression analyses revealed that at the age of three months, female 
gender (OR=2.047; P=0.095) was associated with higher T4 (above the 50th percentile), and 
lower age of the mother (OR=0.931; P=0.176) and breastfeeding (OR=4.615; P=0.004) with 
higher T4S (above the 50th percentile). Formula feeding (OR=2.667; P=0.041) was associated 
with higher TSH at 3 months (above the 50th percentile). At 18 months, higher gestational 
age (OR=1.321; P=0.162) was associated with higher T4 and higher TSH (above the 50th 
percentile). 
After correction for confounders, the Calux result remained significantly associated with 
T4S at three months (OR=1.019; P=0.039). Using univariate logistic regression models, the 
relations between OH-PCBs and TH parameters at three months were not significant. After 
correction for gestational age, 4-OH-PCB-107 was marginally significantly associated with 
T4 at 18 months (OR=1.112; P=0.052), and lower 4’-OH-PCB-172 remained associated with 
higher TSH at 18 months (OR=0.470; P= 0.030; ORs given per 0.01 pg/g fresh weight).
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DISCUSSION
In this study we observed a positive correlation between prenatal background exposure to 
six PCBs and cord serum T3, as well as a negative correlation between exposure to four of 
these six PCBs and cord serum rT3 levels. Five PCBs and the sum of the measured PCBs were 
positively correlated with the T3/rT3 ratio. No effect was found of exposure background 
levels of PCBs or OH-PCBs on T4, T4S, TSH and TBG in cord blood. 4-OH-PCB-107 was 
correlated with T4 at 3 months and T4, T4S and T3 at 18 months. The findings of this study 
suggest that background exposure to PCBs might influence thyroid hormone metabolizing 
enzymes such as iodothyronine deiodinases during fetal life. 4-OH-PCB-107 might have an 
effect after birth. 
Possible mechanisms of PCBs influencing thyroid hormone levels
Studies on animal models have shown effects of PCBs on thyroid function. A number of 
mechanisms have been identified in animals that might play a part: direct negative effects 
on the thyroid gland, competition with TH binding to TTR (the main TH-binding protein in 
rodents), increased biliary excretion of THs, interaction with T3 receptors, interaction with 
the pituitary-thyroid axis, and, finally, changes in the activities of deiodinases (enzymes 
regulating the levels of active THs).17, 20-22 It is unclear which of these mechanisms may play a 
role in the human fetus and newborn. Although the main TH binding protein in humans is not 
TTR, but TBG, TTR still plays a role in mediating the delivery of T4 across the blood-brain 
barrier, transporting T4 into the cerebrospinal fluid, and transferring T4 from the mother 
to the fetus over the placenta.23, 24 Most (>85%) of the hydroxylated PCB metabolites in 
human plasma were found to be associated with human TTR.16 Therefore, it is reasonable to 
suggest that fetal accumulation of hydroxylated PCBs may also occur in human and wildlife 
species.17 During the first half of gestation, fetal TH levels are dependent on maternal T4 
supply. After the onset of fetal TH production, maternal T4 supply to the fetus continues 
to represent an important proportion of TH available to the fetus.25 Different studies have 
shown a negative correlation between PCBs and TH levels in pregnant women.6, 11, 26 Lower 
levels of maternal TH might result in lower TH levels in the fetus. Lower thyroid levels in the 
fetus might negatively influence brain growth and development, as is seen in infants with 
increased levels of TSH at birth.27 Julvez et al. found that low fT4 levels during pregnancy 
were associated with a moderate delay in child development indicating the crucial role 
of perinatal thyroid hormone status for infant development.28 These findings indicate that 




Effects of PCBs on T3 and T3/rT3 ratio
In the present study we showed a positive correlation between a number of PCBs with T3 
in umbilical cord blood, and a negative correlation with rT3. Also, the serum T3/rT3 ratio 
showed a significant positive correlation with PCBs. We did not find a relation between 
the serum lipid concentration and thyroid hormones (data not shown). This suggests that 
the correlations found between PCBs and serum thyroid hormones are not influenced 
by lipid concentration.29 TH homeostasis in humans is regulated by the activities of the 
iodothyronine deiodinases D1, D2 and D3, glucuronidation and sulfation.25 D1 is present in 
the liver, kidney and thyroid gland, and removes iodine from the inner and outer ring. D1 
in adults is considered to be an important source of T3 and responsible for the clearance of 
rT3. D2 is present in the brain, anterior pituitary and thyroid gland. It plays an important 
role in the production of T3 in the brain. D3 is especially present in the fetal brain, placental 
and fetal tissues. D3 catalyzes the inner ring deiodination, resulting in the conversion of T4 
into rT3 and T3 into 3,3’-T2.25 D3 is suggested to play a role in the regulation of intracellular 
T3 levels in tissues such as brain tissue. In placenta and fetal tissues, D3 may protect 
developing tissues against exposure to unduly high levels of active TH.30
The pattern of activity of the deiodinases is different in the fetus and the adult. D2 
activity is relatively low in the fetus.31, 32 D3, however, is found to be very active during 
fetal life, while this activity rapidly decreases after birth.31-34 Due to the high D3 activity, 
especially in placental tissues, fetal rT3 levels are much higher than in the postnatal period, 
whereas the opposite is true for T3. A high D3 activity is not only found in placental tissue, 
but also in human fetal liver and fetal brain tissue.35 The high D3 activities in fetal and 
placental tissues are thought to protect growing tissues against exposure to unduly high T3 
levels. Our results showing a positive correlation between PCB-118, PCB-146, PCB-153, PCB-
138 or PCB-187 and the sum of the measured PCBs and the T3/rT3 ratio, suggest a negative 
effect of these compounds on D3 activity. This correlation was seen both for dioxin-like and 
non-dioxin-like PCBs. The found effects on the T3/rT3 ratio do not seem to be dioxin-related 
effects, because the correlation was not seen for the Calux results, while the dioxin-like 
PCBs were highly significantly correlated with the Calux results. The possible effect of this 
lower D3 activity on the human fetus is still unclear. 
A number of studies, summarized in Table 6, investigated the potential effect of PCBs 
on thyroid hormone levels. It is difficult to compare the results of these studies due to 
differences in methodology. Most studies used maternal serum taken during pregnancy to 
estimate PCB levels, but some studies measured this in cord blood, and single studies used 
placenta tissue and breast milk. The type and number of PCBs varied between studies, with 
some studies expressing results per unit serum, others per g lipid weight. Finally, some 
studies expressed the levels as Toxic Equivalents, TEQ. Thyroid hormones were measured 
either in cord blood, or at 2-21 days after birth. A number of studies, but certainly not 
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all, found a positive correlation between PCBs and TSH. Only a few studies measured T3. 
Koopman-Esseboom et al. found no effect, but measured two weeks after birth.6 Sandau et 
al. found no effect in cord blood in relation to PCBs, but lower levels of T3 when PCBs and 
OH-PCBs were combined.36 Takser et al. found no effect in cord blood.11 Wang et al. found 
a higher level of T3 in girls, not in boys.37 Darnerud et al. found lower levels of T3, but 
measured three weeks after birth.26 Dallaire et al. found no effect in cord blood but only 
measured PCB 153.38 Maervoet et al. found lower levels of fT3 in cord blood.8 Leijs et al. 
reported a positive correlation between PCBs and T3 at the age of 14 to 19 years.39 This is 
in contrast to studies by Koopman-Esseboom et al. and Takser et al. who found lower levels 
of T3 in pregnant woman in relation to PCBs.6, 11 That the effect we found in the present 
study on T3 and rT3 is related to the level of PCBs is unclear. The median level of PCB 153 
was 90.5 ng/g lipid in our study compared to 31.7 in the study of Maervoet et al.8 In the 
studies by Koopman et al., levels are unfortunately only expressed as TEQs and therefore 
not comparable to the results of either Maervoet et al. or the present study. More studies 
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Effects of PCBs on T4, T4S, TSH and TBG
In the present study we did not find an effect of any of the PCBs or OH-PCBs on either T4, 
T4S, TSH or TBG in cord blood, which might be due to the lower levels of PCBs currently 
found in pregnant mothers compared with the levels in our first cohort published in 1994.6 
A number of studies have evaluated the effect of PCBs on TH and TSH levels in newborns 
(Table 6). Mostly cord samples were used to measure the TH status and exposure levels. Two 
European studies with a relatively high background exposure found a negative correlation 
between T4, fT4 and PCBs.6, 8 A number of studies found a positive correlation between PCBs 
and TSH. No effect was seen in studies from Canada and the Faroe Islands. This latter finding 
might be related to high fish consumption in these locations, an important source of both 
PCBs and iodine. For T4, T3 and TSH reference values were available from our laboratory. 
All levels were within the normal range. This, however, does not exclude that PCBs might 
have affected thyroid hormone levels. Reference levels are obtained from infants from the 
Netherlands who were probably exposed to the same background levels of PCBs as individuals 
in our cohort. A lower level within the reference range might have clinical implications. 
Infants with congenital hypothyroidism have poorer neurodevelopmental outcomes, even 
when thyroid hormone levels are within the reference range after early treatment.48 We did 
not find an effect of PCBs on levels of T4S in cord blood, but a positive correlation was found 
between the Calux results and T4S at 3 months and the sum OH-PCB and T4S at 18 months. 
This might indicate that although the prevailing PCB concentrations do not influence the 
sulfation of T4 during fetal life, it may still exert an effect in early childhood. 
Effects of OH-PCBs on TH metabolism
We did not observe a correlation between any of the OH-PCBs and TH levels in cord blood. 
Sandau et al. reported a negative correlation between sum OH-PCBs and fT4, while Otake 
et al. observed a positive correlation.36, 42 We found that 4-OH-PCB-107 showed a positive 
effect on T4 at both three and 18 months, while 4’-OH-PCB-172 showed a negative effect 
on TSH at both three and 18 months. Whether OH-PCBs have an effect on human TH levels, 
or are currently present at levels too low to have an effect, is not clear. It is interesting 
to note that different studies found an effect of 4-OH-PCB-107 on neurodevelopment.10, 14, 
15 Whether this effect on neurodevelopment is related to effects on the thyroid hormones, 
needs further study. 
A strength of our study is that we evaluated the effect of PCBs on the activity of 
deiodinases and sulfotransferase in human infants. To our knowledge, this is the first study 
evaluating whether PCBs might have an effect on the activity of these thyroid hormone 
metabolizing enzymes in human infants. A study in rats shows that PCBs competitively 
inhibit T4 binding to TTR and type I deiodinase (D1) activity.19 Another study by Morse et 
al. shows that reductions in brain T4 levels were most severe in the fetus, and that the 
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induction of D2 activity in the fetal forebrain can account for the maintenance of forebrain 
T3 levels in the fetus.12 It has been suggested that type III iodothyronine 5-deiodinase (D3) 
regulates cerebellar T3 levels by regulating the deiodination of T3 to T2. A second strength 
is that in addition to the effects of PCBs, we also investigated whether prenatal exposure 
to OH-PCBs might have effects on thyroid hormone metabolism. A third strong point is that 
we measured thyroid hormone parameters at several time points. We measured thyroid 
hormone parameters in cord blood, and in samples of infants at the age of three and 18 
months.
We also recognize limitations to this study. A first limitation is that we have a relatively 
small study group. We evaluated the effects of PCBs on thyroid hormone parameters in 100 
mother-infant pairs. Because of the relatively small study group, the results need to be 
interpreted with caution, and larger studies are needed to confirm our results. A second 
limitation is that we only investigated the effects of PCBs until the age of 18 months. In our 
study, we did not find effects of prenatal exposure to PCBs or OH-PCBs on thyroid hormone 
parameters at the age of three and 18 months. It is not clear whether the associations found 
between PCBs and OH-PCBs and thyroid hormone parameters in cord blood might have 
consequences for developmental processes after the age of 18 months. Leijs et al. found 
a positive correlation between dioxin-like PCBs and T3 levels in infants at the age of 14 to 
18 years old.39 To assess whether our findings have consequences for hormone metabolism 
and developmental outcomes at later age, we are currently working on a follow-up study, 
in which we will measure levels of several PCBs and thyroid hormone parameters during 
adolescence. A further limitation is that other environmental pollutants, like brominated 
compounds, may have the same effects as PCBs. We found no correlation between the Calux 
results in cord blood and thyroid hormones. The Calux is an overall measure of dioxin-like 
compounds. Still, we found a correlation between the T3/rT3 ratio and the dioxin-like PCBs. 
This suggests that the effect of the dioxin-like PCBs on the T3/rT3 ratio is not mediated 
by the AhR receptor. This is also supported by the finding that non-dioxin-like PCBs also 
influenced the T3/rT3 ratio. It might also be that different dioxin-like compounds might 
have different, sometimes opposing, effects. However, it is difficult to study this in humans, 
as all humans are subjected to combinations of compounds. Studies in animals might not 
reflect the metabolism of these compounds in humans. 
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CONCLUSIONS
In conclusion, prenatal background exposure to several PCBs influences cord T3 and rT3 
levels, giving indications for reduced D3 activity. No effect was found on T4, T4S, T3, TSH 
and TBG in infants at three and 18 months. 4-OH-PCB-107 was related to thyroid hormones 
at the age of 3 and 18 months. Our findings suggest that prenatal background exposure to 
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SUPPLEMENTARY MATERIAL
Table S1. Spearman’s rho correlations between prenatal PCBs and Calux











Sum PCBsa 0.227 0.026*
dl-PCBsb 0.327 0.001**
non-dl-PCBsc 0.190 0.063
Calux: Chemical-activated luciferase gene expression; a Sum PCBs: sum of all 10 measured PCBs; b Sum 
dl-PCBs: sum of dioxin-like PCBs (105; 118; 156); c Sum non-dl-PCBs: sum of non-dioxin-like PCBs (138; 
146; 153; 170; 180; 183; 187);*P<.05;**P<.01

